Your browser doesn't support javascript.
loading
Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis.
Allegretta, Caterina; Difonzo, Graziana; Caponio, Francesco; Tamma, Grazia; Laselva, Onofrio.
Afiliación
  • Allegretta C; Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Difonzo G; Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
  • Caponio F; Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
  • Tamma G; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, 70125 Bari, Italy.
  • Laselva O; Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Cells ; 12(13)2023 07 01.
Article en En | MEDLINE | ID: mdl-37443798
The deletion of phenylalanine at position 508 (F508del) produces a misfolded CFTR protein that is retained in the ER and degraded. The lack of normal CFTR channel activity is associated with chronic infection and inflammation which are the primary causes of declining lung function in Cystic Fibrosis (CF) patients. Moreover, LPS-dependent oxidative stress downregulates CFTR function in airway epithelial cells. Olive leaf extract (OLE) is used in traditional medicine for its effects, including anti-oxidant and anti-inflammatory ones. We found that OLE decreased the intracellular ROS levels in a dose-response manner in CFBE cells. Moreover, OLE attenuates the inflammatory response to LPS or IL-1ß/TNFα stimulation, mimicking the infection and inflammatory status of CF patients, in CFBE and primary nasal epithelial (HNE) cells. Furthermore, we demonstrated that OLE restored the LPS-mediated decrease of TrikfaftaTM-dependent F508del-CFTR function in CFBE and HNE cultures. These findings provide strong evidence of OLE to prevent redox imbalance and inflammation that can cause chronic lung damage by enhancing the antioxidant activity and attenuating inflammation in CF airway epithelial cells. Additionally, OLE might be used in combination with CFTR modulators therapy to improve their efficacy in CF patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística Límite: Humans Idioma: En Revista: Cells Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística Límite: Humans Idioma: En Revista: Cells Año: 2023 Tipo del documento: Article País de afiliación: Italia